Swedish study finds diets may ease IBS symptoms better than medication

Date:

Share this article:

Del denne artikel:

New research suggests that dietary changes could outperform traditional drugs in relieving symptoms of irritable bowel syndrome (IBS).

Irritable bowel syndrome affects around one in ten adults and is marked by abdominal pain, bloating, and irregular bowel habits.

There is no cure, and medications often bring only limited relief.

In recent years, doctors have turned increasing attention to diet, particularly the low-FODMAP approach, which reduces hard-to-digest carbohydrates that ferment in the gut.

Previous research published in Nutrients hinted that a low-carbohydrate plan might also help.

Also read: Scientists uncover the cell’s secret weapon against aging

A Swedish study published in The Lancet Gastroenterology and Hepatology have now compared these two diets directly with standard medication to see which brings the most relief.

Comparing diet and medicine

Researchers at the University of Gothenburg enrolled nearly 300 people with moderate to severe IBS.

Participants were assigned to one of three groups: personalized medication, a low-FODMAP diet with standard IBS guidance, or a strict low-carb plan allowing about 50 grams of carbohydrates daily.

After four weeks, most participants reported improvement, but diet clearly made the biggest difference.

Also read: A dim light while you sleep could harm your heart, study suggests

About three-quarters of those on the low-FODMAP plan and seven in ten on the low-carb diet experienced meaningful relief, compared with just over half in the medication group.

The findings surprised researchers who had expected FODMAP restrictions to outperform low-carb eating by a wider margin.

Long-Term lessons and cautions

When checked six months later, many participants still felt better, even though they had relaxed their diets somewhat.

This suggests that even modest carbohydrate reduction might help control symptoms.

Also read: How to recognize the early signs of knee osteoarthritis

Experts note, however, that restrictive diets can be difficult to sustain and may limit social eating or nutrient intake.

Doctors recommend reintroducing foods gradually and tailoring plans to each patient.

The study’s lead author, Sanna Nybacka, told The New York Times that many participants chose to return to stricter eating patterns when their symptoms flared.

While diet may not replace medication for everyone, the research points toward a future where managing IBS depends less on pills, and more on what’s on the plate.

Also read: Ordinary routines matter more than wellness trends

Sources: Forskning.no, Nutrients, and The Lancet Gastroenterology and Hepatology.

Also read: Norwegian researchers found that older adults need more protein

This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.

Other articles

A single brain protein may drive aging, and old mice bounced back in about a month

The clue researchers chased sits in a small corner of the brain that quietly steers almost everything else.

The most effective quit-smoking tool has been found

The biggest evidence review yet on how to stop smoking has a clear answer, and it is not the one most doctors still reach for first.

Promising lung cancer drug hits major setback just days before FDA decision

A promising treatment for one of the deadliest lung cancers has hit a setback that experts did not see coming.

Your eyeliner and mascara may be more dangerous than you think, data shows

The familiar tubes sitting on your bathroom shelf are sending people to the emergency room more often than you would guess.

A single brain protein may drive aging, and old mice bounced back in about a month

The clue researchers chased sits in a small corner of the brain that quietly steers almost everything else.

The most effective quit-smoking tool has been found

The biggest evidence review yet on how to stop smoking has a clear answer, and it is not the one most doctors still reach for first.

Promising lung cancer drug hits major setback just days before FDA decision

A promising treatment for one of the deadliest lung cancers has hit a setback that experts did not see coming.